Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive ...
Q1 2026
May 6, 2026
FY 2025
Mar 18, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 6, 2025